Angiotensin II formulations and their impact on reproducibility, reduction and refinement (3R) of the animal models of hypertension.
Event:
Frontiers in CardioVascular Biomedicine 2022
Topic:
Basic Science, Other
Session:
Late-Breaking Science - Poster session 2